Detalles de la búsqueda
1.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199127
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
3.
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Haematologica
; 106(12): 3079-3089, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179471
4.
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Cancers (Basel)
; 15(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672386
5.
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Blood Cancer J
; 13(1): 77, 2023 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173322
6.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005697
7.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
8.
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.
Cancer Med
; 12(14): 14892-14901, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212507
9.
Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry.
Leuk Res
; 115: 106821, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35286939
10.
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.
Blood Adv
; 6(4): 1278-1295, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794172
11.
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.
Transplant Cell Ther
; 27(4): 311.e1-311.e10, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836871
12.
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
Leukemia
; 35(6): 1571-1585, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077867
13.
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.
Leuk Res
; 92: 106352, 2020 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240863
14.
Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].
Leuk Res
; 96: 106388, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32680618
Resultados
1 -
14
de 14
1
Próxima >
>>